Wynnefield Capital Inc.
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 14, 2026), Wynnefield Capital Inc. reported 8 stock positions worth $145.4 million. Its top holding was Natures Sunshine Prods (NATR) at 37.1% of the portfolio, followed by Cadre (CDRE, 23.6%) and Lifecore Biomedical (LFCR, 17.0%). Compared with Q1 2026, it sold out of 1 and added to 1. The biggest buy was Cadre (CDRE, shares +5%) and the biggest sale an exit from NN (NNBR).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001251567
- Portfolio Value
- $145.4M (Q2 2026)
- SEC Filing
- 0001104659-26-097115 ↗ filed Aug 14, 2026
Holdings Value
Holdings 8 stocks · $145.4M
| NATR Natures Sunshine Prods Inc. | 37.09% | 2,473,686 | $53.9M | No change |
| CDRE Cadre Holdings Inc. | 23.63% | 1,205,000 | $34.4M | Add +4.8% |
| LFCR Lifecore Biomedical Inc. | 16.98% | 4,703,216 | $24.7M | No change |
| DLHC DLH Holdings Corp. filed as DLH HLDGS CORP | 13.29% | 3,681,421 | $19.3M | No change |
| AEM Agnico Eagle Mines Ltd. | 3.73% | 35,000 | $5.4M | No change |
| QRHC Quest Resource Holding Corp. | 2.37% | 2,734,349 | $3.4M | No change |
| TPCS Techprecision Corp. | 1.56% | 433,605 | $2.3M | No change |
| SIL Global X Silver Miners ETF | 1.33% | 25,000 | $1.9M | No change |
Portfolio Sells Q1 2026 → Q2 2026
| NNBR NN Inc. | Sold out | 0.00% | −0.03 |
Portfolio Buys Q1 2026 → Q2 2026
| CDRE Cadre Holdings Inc. | Add +4.8% | 23.63% | −0.29 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 8 | $145.4M | NATR, CDRE, LFCR, DLHC, AEM |
| Q1 2026 | 9 | $147.5M | NATR, CDRE, DLHC, LFCR, AEM |
| Q4 2025 | 12 | $177.8M | NATR, CDRE, LFCR, DLHC, STKL |
| Q3 2025 | 15 | $166.4M | CDRE, NATR, LFCR, DLHC, STKL |
| Q2 2025 | 16 | $169.5M | LFCR, NATR, CDRE, DLHC, AEM |
| Q1 2025 | 16 | $158.0M | CDRE, LFCR, NATR, AEM, DLHC |
| Q4 2024 | 16 | $219.4M | AEM, CDRE, NATR, LFCR, DLHC |
| Q3 2024 | 17 | $224.7M | CDRE, AEM, DLHC, NATR, LFCR |
| Q2 2024 | 17 | $222.5M | CDRE, DLHC, NATR, AEM, LFCR |
| Q1 2024 | 23 | $251.7M | NATR, DLHC, CDRE, AEM, LFCR |